SEC 13F Intelligence

Aperio Group, LLC / JNJ

Aperio Group, LLC’s Johnson & Johnson Position

Does Aperio Group, LLC own Johnson & Johnson (JNJ)? Yes — 2.38M shares worth $375M (+1.11% of its 13F portfolio) as of Q4 2020, down from 2.52M shares the prior filed quarter.

Position Value
$375M
Q4 2020
Shares
2.38M
% of Portfolio
+1.11%
Quarters Held
9
currently held

Position History JNJ

Reported value by quarter
Q4 ’18: $260MQ4 ’18Q1 ’19: $289MQ2 ’19: $309MQ2 ’19Q3 ’19: $284MQ4 ’19: $358MQ4 ’19Q1 ’20: $319MQ2 ’20: $350MQ2 ’20Q3 ’20: $375MQ4 ’20: $375MQ4 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20202.38M$375M+1.11%
Q3 20202.52M$375M+1.27%
Q2 20202.49M$350M+1.29%
Q1 20202.43M$319M+1.41%
Q4 20192.45M$358M+1.29%
Q3 20192.19M$284M+1.12%
Q2 20192.22M$309M+1.26%
Q1 20192.07M$289M+1.25%
Q4 20182.01M$260M+1.30%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aperio Group, LLC’s full portfolio or all institutional holders of JNJ.